 |
市场调查报告书
商品编码
1559497
2024-2029 年全球组织诊断产业的成长机会Growth Opportunities in the Tissue Diagnostics Industry, Global, 2024-2029 |
||||||
专门用于伴同性诊断的先进染色和多组体学功能将推动市场成长
由于个人化医疗中需要先进的染色来准确识别生物标记、组织切片检查的检测量以及预分析和先进染色平台的开发，预计全球组织诊断市场将显着增长。
据世界卫生组织称，到 2040 年，全球癌症病例预计将增加 60%，从而推动对组织诊断的需求。这一增长凸显了改进诊断工具的迫切需求。由于癌症治疗的进步，组织诊断的复杂性不断增加，需要世界各地实验室改进技术和能力。提高本地诊断能力对于管理全球癌症发病率的预测成长至关重要，因为它可以缩短测试週转时间并提高诊断准确性。
组织诊断产业的分析前染色市场由几个关键因素推动，包括染色技术的进步、简化次世代定序前平台、自动化染色平台以及提高效率和重现性的高通量系统。组织诊断领域的参与者越来越注重开发创新和先进的系统和染色剂，以提高组织诊断的特异性和敏感性。特别是，这是由于对 ISH 和 IHC 的需求增加、将 CDx 作为病理测试一部分的强制性法规，以及生物製药公司和诊断药物公司之间合作的加强。
亚太地区癌症诊断基础设施的成长、癌症发生率的增加、医疗保健支出的增加、先进诊断技术的普及以及政府支持的扩大，都使该地区成为成长最快的市场。
目录
全球组织诊断产业的转型
- 为什么成长如此困难？
- The Strategic Imperative 8（TM）
- 全球组织诊断产业三大策略问题的影响
组织诊断产业的成长环境—生态系统
- 分析范围
- 分割
成长环境：企业行为
- 竞争环境
- 主要竞争对手（按技术划分）
成长机会分析：组织诊断产业的成长动力
- 成长指标
- 生长促进因子
- 成长抑制因素
- 组织诊断产业的趋势
- 预测方法和假设
- 收益和预测
- 收益和预测分析
- 按技术分類的收益预测
- 主要成长机会 - 组织诊断领域
- 地区收益预测
- 区域收益分析-NA
- 组织诊断市场动态-NA
- 区域收益分析 - 欧洲
- 组织诊断市场动态- 欧洲
- 区域收益分析 - 亚太地区
- 组织诊断的市场动态- 亚太地区
- 区域收益分析 - MENASA 和拉丁美洲
- 最终用户的收益预测
- 最终用户收益分析
- 收益占有率
- 收益占有率分析
- 竞赛矩阵
- 全球组织诊断市场－值得注意的活动
- 组织诊断的商业机会与创新蓝图
生长机会分析：分析前染色中的生长发生器
- 生长指示剂-预处理染色
- 分析前染色收益预测
- 预分析染色收益预测分析
- 预分析染色收益预测分析
生长机会分析：高级染色中的生长发生器
- 生长指标-高阶染色
- 先进染色收益预测
- 进阶染色 -收益预测分析
- FDA核准的基于组织的伴随诊断清单，2022-2023 年
成长机会分析：ICP-APLIS 成长产生器
- 生长指标-ICP-APLIS
- ICP-APLIS收益预测
- ICP-APLIS-收益预测分析
- ICP-APLIS-收益预测分析
存取控制解决方案的成长机会领域
- 成长机会 1 - 用于早期识别癌症生物标记的综合诊断组合
- 成长机会2－多组体学分析实现精准诊断
- 成长机会 3 - 用于基于组织的伴同性诊断的数位病理学功能
最佳实践认证
- 最佳实践评估
FROST RADAR
- FROST RADAR
下一步
- 成长机会的好处和影响
- 下一步
- 图表列表
- 免责声明
Companion Diagnostics-specific Advanced Staining and Multiomics Capabilities are Driving Market Growth
The global tissue diagnostics market will experience significant growth driven by the need for advanced staining in precise biomarker identification in personalized medicine, tissue biopsy test volumes, and pre-analytical and advanced staining platform development.
According to the WHO, there will be a 60% rise in cancer cases worldwide by 2040, which will fuel demand for tissue diagnostics. This increase highlights how urgently improved diagnostic tools are needed. The complexity of tissue diagnostics expanded due to advancements in cancer treatment, which require enhanced technology and capabilities in laboratories across the globe. Improving local diagnostic capacity is vital for managing the projected growth in cancer incidence worldwide, as it can improve test turnaround times and diagnostic accuracy-both of which substantially impact cancer treatment outcomes.
The pre-analytical staining market in the tissue diagnostics industry is being propelled by several key factors, such as growing advancements in staining technologies, pre-analytical platforms to simplify next-generation sequencing, automated staining platforms, and high-throughput systems to drive efficiency and reproducibility. Tissue diagnostics players are increasingly focusing on developing innovative and advanced systems and stains that enhance the specificity and sensitivity of tissue diagnostics. The advanced staining segment is the second leading segment due to a surge in adoption, especially driven by increased demand for ISH and IHC offerings, regulatory mandates to include CDx as part of pathology tests, and increased partnerships between biopharma companies and diagnostic companies.
Asia-Pacific's growing cancer diagnostics infrastructure, increasing cancer prevalence rate, rising healthcare spending, increasing access to advanced diagnostic technologies, and growing government support all contribute to the region being the fastest-growing market.
Table of Contents
Transformation in Global Tissue Diagnostics Industry
- Why is it Increasingly Difficult to Grow?
- The Strategic Imperative 8™
- The Impact of the Top 3 Strategic Imperatives on the Global Tissue Diagnostic Industry
Growth Environment-Ecosystem in Tissue Diagnostics Industry
- Scope of Analysis
- Segmentation
Growth Environment-Companies to Action
- Competitive Environment
- Key Competitor by Technology
Growth Opportunity Analysis-Growth Generator in Tissue Diagnostics Industry
- Growth Metrics
- Growth Drivers
- Growth Restraints
- Trends in the Tissue Diagnostics Industry
- Forecast Methodology and Assumptions
- Revenue Forecast
- Revenue Forecast Analysis
- Revenue Forecast by Technology
- Primary Growth Opportunities-Tissue Diagnostics Segments
- Revenue Forecast by Region
- Revenue Forecast Analysis by Region-NA
- Tissue Diagnostics Market Dynamics-NA
- Revenue Forecast Analysis by Region-Europe
- Tissue Diagnostics Market Dynamics-Europe
- Revenue Forecast Analysis by Region-APAC
- Tissue Diagnostics Market Dynamics-APAC
- Revenue Forecast Analysis by Region-MENASA & Latin America
- Revenue Forecast by End User
- Revenue Forecast Analysis by End User
- Revenue Share
- Revenue Share Analysis
- Competitor Matrix
- Global Tissue Diagnostics Market-Notable Activities
- Tissue Diagnostics Opportunity and Innovations Roadmap
Growth Opportunity Analysis-Growth Generator in Pre-Analytical Staining
- Growth Metrics-Pre-Analytical Staining
- Pre-analytical Staining Revenue Forecast
- Pre-analytical Staining Revenue Forecast Analysis
- Pre-analytical Staining Revenue Forecast Analysis
Growth Opportunity Analysis-Growth Generator in Advanced Staining
- Growth Metrics-Advance Staining
- Advanced Staining Revenue Forecast
- Advanced Staining-Revenue Forecast Analysis
- List of FDA-approved Tissue-based CDx, 2022-2023
Growth Opportunity Analysis-Growth Generator in ICP-APLIS
- Growth Metrics-ICP-APLIS
- ICP-APLIS Revenue Forecast
- ICP-APLIS-Revenue Forecast Analysis
- ICP-APLIS-Revenue Forecast Analysis
Growth Opportunity Universe in Access Control Solutions
- Growth Opportunity 1-Comprehensive Diagnostic Panels for Early Identification Of Cancer Biomarkers
- Growth Opportunity 2-Multiomics Analysis for Precision Diagnostics
- Growth Opportunity 3-Digital Pathology Capabilities for Tissue-based Companion Diagnostics
Best Practices Recognition
- Best Practices Recognition
Frost Radar
- Frost Radar
Next Steps
- Benefits and Impacts of Growth Opportunities
- Next Steps
- List of Exhibits
- Legal Disclaimer
组织诊断市场规模、份额、趋势分析报告：2025-2030 年按技术、应用、最终用途、地区和细分市场进行的预测
组织诊断市场：按产品、技术、适应症和最终用户划分 - 全球预测 2025-2030
组织诊断市场规模、份额、成长分析、按产品类型、按技术、按疾病类型、按最终用户、按地区 - 行业预测，2024-2031 年
组织诊断市场，按技术、按应用、按最终用户、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测
全球癌症组织诊断市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测
全球组织诊断市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测
2024-2032 年按产品类型、技术、疾病、最终用户和地区分類的组织诊断市场报告
全球组织诊断市场规模、份额和趋势分析报告：按产品、按技术、按疾病类型、按最终用户、按地区、展望和预测，2023-2030
组织诊断的全球市场（~2028）：产品（消耗品（抗体、试剂、组织、探针）、设备（处理系统、扫描器））、技术（ISH、IHC、玻片染色）、疾病类型（乳房癌症、淋巴瘤・前列腺癌）分开
组织诊断市场、份额、规模、趋势、行业分析报告：按产品、技术、疾病、应用、地区、细分市场预测，2024-2032